BIOLASE (NASDAQ:BIOL) Now Covered by StockNews.com

StockNews.com started coverage on shares of BIOLASE (NASDAQ:BIOL) in a report released on Friday. The firm issued a sell rating on the medical technology company’s stock.

BIOLASE Price Performance

Shares of BIOL stock opened at $0.01 on Friday. The company has a market capitalization of $310,685.10, a P/E ratio of 0.00 and a beta of 0.67. The company’s 50-day simple moving average is $0.01 and its two-hundred day simple moving average is $0.03. BIOLASE has a one year low of $0.02 and a one year high of $1.94.

About BIOLASE

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.